0001571049-16-011673.txt : 20160211 0001571049-16-011673.hdr.sgml : 20160211 20160211162648 ACCESSION NUMBER: 0001571049-16-011673 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160211 DATE AS OF CHANGE: 20160211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78682 FILM NUMBER: 161411903 BUSINESS ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631-240-8800 MAIL ADDRESS: STREET 1: 50 HEALTH SCIENCES DRIVE CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Hayward James A CENTRAL INDEX KEY: 0001357784 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: C/O 25 HEALTH SCIENCES DRIVE STREET 2: SUITE 113 CITY: NEW YORK STATE: NY ZIP: 11790 SC 13G/A 1 t1600056_sc13ga.htm SCHEDULE 13G AMENDMENT NO. 1

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934 

(Amendment No. 1)*

 

Applied DNA Sciences, Inc.

 

 

(Name of Issuer)

 

Common Stock, $0.001 par value

 

 

(Title of Class of Securities)

 

03815U 201

 

 

(CUSIP Number)

 

December 31, 2015

 

 

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

 Rule 13d-1(b)

 

 Rule 13d-1(c)

 

 Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 6 pages

 

 

 
 

 

 CUSIP No. 03815U 201 SCHEDULE 13G Page 2 of 6 Pages 

       
1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

James A. Hayward

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  ☐          
(b)  

3

SEC USE ONLY

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

United States

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH:

5

SOLE VOTING POWER

 

3,843,016[1]

6

SHARED VOTING POWER

 

0

7

SOLE DISPOSITIVE POWER

 

3,843,016

8

SHARED DISPOSITIVE POWER

 

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

3,843,016

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

 

o

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

16.0%[2]

12

TYPE OF REPORTING PERSON (See Instructions)

 

IN

 

 

 

1

Includes 1,923,762 shares underlying options and warrants exercisable within 60 days. Such number reflects (i) the expiration, pursuant to their terms, of options to purchase 283,334 shares and warrants to purchase 3,638 shares and (ii) the vesting of options to purchase 208,334 shares, in each case, during the calendar year ended December 31, 2015.

2This percentage calculation is based on 24,072,092 outstanding shares as of December 31, 2015.

 

 
 

 

   
 CUSIP No. 03815U 201 SCHEDULE 13G Page 3 of 6 Pages 
       

 

Item 1.

 

  (a) Name of Issuer:
  Applied DNA Sciences, Inc.

 

  (b) Address of Issuer’s Principal Executive Offices:
  50 Health Sciences Drive, Stony Brook, New York 11790

 

Item 2.

 

  (a) Name of Person Filing:
  James A. Hayward

 

  (b) Address of Principal Business Office or, if None, Residence:
  50 Health Sciences Drive, Stony Brook, New York 11790

 

  (c) Citizenship:
  United States

 

  (d) Title of Class of Securities:
  Common Stock, $0.001 par value

 

  (e) CUSIP Number:
  03815U 201

 

 
 

 

 CUSIP No. 03815U 201 SCHEDULE 13G Page 4 of 6 Pages 

 

Item 3. If This Statement Is Filed Pursuant to Rule 13d-1(b) or Rule 13d-2(b) or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o)

 

  (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)

 

  (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)

 

  (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)

 

  (e) An investment adviser in accordance with section 240.13d-1(b)(1)(ii)(E)

 

  (f) An employee benefit plan or endowment fund in accordance with section 240.13d-1(b)(1)(ii)(F)

 

  (g) A parent holding company or control person in accordance with section 240.13d-1(b)(1)(ii)(G)

 

  (h) A savings association as defined in section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)

 

  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)

 

  (j) A non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J)

 

  (k) Group, in accordance with section 240.13d-1(b)(1)(ii)(K)

 

  If filing as a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not applicable

  

Item 4. Ownership.

 

  (a)

Amount beneficially owned:

3,843,016 (See Footnote 1, Page 2)

 

  (b)

Percent of class:

16.0% (See Footnote 2, Page 2)

 

  (c) Number of shares as to which the person has:

 

  (i)

Sole power to vote or to direct the vote

3,843,016

 

  (ii)

Shared power to vote or to direct the vote

0

 

  (iii)

Sole power to dispose or to direct the disposition of

3,843,016

 

  (iv)

Shared power to dispose or to direct the disposition of

0

 

 
 

 

       
 CUSIP No. 03815U 201 SCHEDULE 13G Page 5 of 6 Pages 

 

Item 5. Ownership of 5 Percent or Less of a Class.

 

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following:

 

Instruction: Dissolution of a group requires a response to this item.

 

Not Applicable.

 

Item 6. Ownership of More than 5 Percent on Behalf of Another Person.

 

Not Applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not Applicable.

 

Item 8. Identification and Classification of Members of the Group.

 

Not Applicable.

 

Item 9. Notice of Dissolution of Group.

 

Not Applicable.

 

Item 10. Certification.

 

Not Applicable. 

 

 
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 11, 2016

 

  /s/ James A. Hayward  
  James A. Hayward  

 

Page 6 of 6 Pages